Literature DB >> 15724345

Quality of life of patients with allergic contact dermatitis: an exploratory analysis by gender, ethnicity, age, and occupation.

Deana L Kadyk1, Sandra Hall, Donald V Belsito.   

Abstract

BACKGROUND: Little has been published regarding the impact of gender, ethnicity, age, and occupation on the quality of life (QoL) of patients with allergic contact dermatitis (ACD).
OBJECTIVES: This study investigated the relationship between QoL scores for patients with ACD and variables such as gender, ethnicity, age, and occupation.
METHODS: Four hundred twenty-eight patients with ACD were mailed a QoL questionnaire modified from Skindex-16 to include an additional five items pertaining to occupational impact. The QoL scores were analyzed to ascertain factors that affect QoL in patients with ACD.
RESULTS: The response rate was 35%. Non-Caucasians reported lower QoL scores than did Caucasians within the functioning scale. There were no statistically significant gender-related differences in QoL scores although females reported a higher degree of emotional distress. Younger subjects were more likely to have lower QoL scores within the functioning and occupational scales. Industrial workers reported the worst occupational QoL, followed by office workers. Occupation was the variable that significantly affected the greatest number of survey subjects, followed by age, ethnicity, and gender.
CONCLUSIONS: Three of the four variables examined had a significant association with QoL. Non-Caucasians, younger subjects, and industrial workers reported a significantly worse QoL due to ACD. There were no statistically significant gender-related differences in QoL scores.

Entities:  

Mesh:

Year:  2004        PMID: 15724345     DOI: 10.2310/6620.2004.04007

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  5 in total

1.  Occupational and non-occupational allergic contact dermatitis and quality of life: a prospective study.

Authors:  Catiussa Spode Brutti; Renan Rangel Bonamigo; Taciana Cappelletti; Gabriela Mynarski Martins-Costa; Ana Paula Salin Menegat
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

Review 2.  The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis.

Authors:  Joshua L Owen; Paras P Vakharia; Jonathan I Silverberg
Journal:  Am J Clin Dermatol       Date:  2018-06       Impact factor: 7.403

3.  Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells.

Authors:  Mercedes Gomez de Agüero; Marc Vocanson; Fériel Hacini-Rachinel; Morgan Taillardet; Tim Sparwasser; Adrien Kissenpfennig; Bernard Malissen; Dominique Kaiserlian; Bertrand Dubois
Journal:  J Clin Invest       Date:  2012-04-23       Impact factor: 14.808

4.  Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10.

Authors:  Botond Z Igyarto; Matthew C Jenison; Jan C Dudda; Axel Roers; Werner Müller; Pandelakis A Koni; Daniel J Campbell; Mark J Shlomchik; Daniel H Kaplan
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

Review 5.  Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder.

Authors:  Ester Di Agosta; Lorenzo Salvati; Monica Corazza; Ilaria Baiardini; Francesca Ambrogio; Luisa Angileri; Elettra Antonelli; Federica Belluzzo; Domenico Bonamonte; Laura Bonzano; Raffaele Brancaccio; Paolo Custurone; Aurora De Marco; Aikaterini Detoraki; Adriana Di Guida; Elisabetta Di Leo; Marta Fantò; Filippo Fassio; Silvia Mariel Ferrucci; Caterina Foti; Rosella Gallo; Alessia Gatta; Fabrizio Guarneri; Lucia Guidolin; Katharina Hansel; Donatella Lamacchia; Carla Lombardo; Paola Lucia Minciullo; Maddalena Napolitano; Alessandro Pannofino; Andrea Paravisi; Roberta Parente; Maria Passante; Cataldo Patruno; Diego Peroni; Cristina Quecchia; Natale Schettini; Giuseppe Spadaro; Luca Stingeni; Daniele Tarrini; Marta Tramontana; Eustachio Nettis; Oliviero Rossi
Journal:  Clin Mol Allergy       Date:  2021-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.